查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球口服补液 (ORS) 市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1342825

全球口服补液 (ORS) 市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Oral Rehydration Solution (ORS) Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

全球口服补液溶液（ORS）市场需求预计将从2022年的5.77万美元达到2030年近16.03万美元的市场规模，2023-2030年研究期间复合年增长率为12.02%。

口服水合溶液是一种防止脱水的液体。患有腹泻或呕吐的患者会失去水分和电解质。口服补液将丢失的水分和电解质补充回体内，防止脱水。它通常由水和少量糖以及含有钠和钾的盐组成。它还由锌元素组成。口服补液可以直接摄入或通过鼻胃管给予。它有助于在各种病毒或细菌感染期间保持身体水分。

市场动态：

发展中国家的不洁净水会导致腹泻，从而导致对口服补液溶液的需求增加。口服补液盐市场的儿科市场预计在未来几年将增长最快。由于不健康和压力大的生活方式，人们脱水的情况不断增加，进一步增加了对口服补液解决方案的需求，从而导致市场增长。医院患者和普通人群发病率和死亡率的上升增加了当地药剂师对 ORS 的供应需求，直接推动了 OPRS 全球市场的发展。政府积极宣传口服补液盐的好处以及人们对口服补液盐积极影响的认识，正在进一步推动其市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球口服补液盐 (ORS) 市场的各个细分市场进行了包容性评估。口服补液盐行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲口服补液溶液市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。口服补液盐 (ORS) 市场的主要参与者包括 FDC Limited、Cipla、Wallace Pharmaceuticals、Zydus Cadila Healthcare Ltd、Shereya Life Sciences、Mankind Pharma、Intas Pharmaceuticals Ltd.、Sun Pharma、Dr Reddy's、Alkem、Lupin、Cadila、 RPG生命科学，Casca Remedies Pvt。有限公司，哈尔伍德实验室列兵。有限公司、Healthy Life Pharma Private Limited、Okasa Pharma Pvt.该部分包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：口服补液溶液 (ORS) - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品销售进行的市场吸引力分析
    • 按剂型分類的市场吸引力分析
    • 按客户年龄分類的市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 按分销渠道分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球口服补液 (ORS) 市场分析：按产品销售

  • 按产品销售情况概览
  • 历史和预测数据
  • 按产品销量分析
  • 非处方药产品
  • 处方

第 7 章：全球口服补液 (ORS) 市场分析：按剂型

  • 按剂型概述
  • 历史和预测数据
  • 按剂型分析
  • 粉末
  • 液体
  • 药片

第 8 章：全球口服补液溶液 (ORS) 市场分析：按客户年龄

  • 按客户年龄分類的概览
  • 历史和预测数据
  • 按顾客年龄分析
  • 孩子们
  • 成人

第 9 章：全球口服补液 (ORS) 市场分析：按适应症分类

  • 按适应症概述
  • 历史和预测数据
  • 按指标分析
  • 腹泻
  • 胃肠炎
  • 电解质不平衡
  • 其他的

第 10 章：全球口服补液 (ORS) 市场分析：按分销渠道

  • 按分销渠道分類的概览
  • 历史和预测数据
  • 按分销渠道分析
  • 医院药房
  • 零售药店
  • 网上药店

第 11 章：全球口服补液溶液 (ORS) 市场分析：按地理位置

  • 顶级公司股票分析
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：口服补液 (ORS) 公司的竞争格局

  • 口服补液（Ors）市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 公司股份分析
  • 市场集中度
  • FDC Limited
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cipla
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Wallace Pharmaceuticals
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Zydus Cadila Healthcare Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Shereya Life Sciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Mankind Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Intas Pharmaceuticals Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sun Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dr Reddy's
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Alkem
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lupin
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cadila
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • RPG Life Sciences
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Casca Remedies Pvt. Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Halewood Laboratories Pvt. Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Healthy Life Pharma Private Limited
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Okasa Pharma Pvt. Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR11219611

The global demand for Oral Rehydration Solution (ORS) Market is presumed to reach the market size of nearly USD 16.03 MN by 2030 from USD 5.77 MN in 2022 with a CAGR of 12.02% under the study period 2023 - 2030.

Oral hydration solution is a fluid that prevents dehydration. The patient suffering from diarrhoea or vomiting loses water and electrolytes. Oral rehydration solution replenishes that lost water and electrolytes back into the body, preventing dehydration. It usually consists of water with small amounts of sugars and salts containing sodium and potassium. It also consists of zinc elements. Oral rehydration solution can be ingested directly or given by a nasogastric tube. It helps to keep the body hydrated during various viral or bacterial infections.

MARKET DYNAMICS:

The presence of unclean water in developing countries causes diarrhoea which causes a rise in demand for oral rehydration solutions. The pediatric segment of the oral rehydration solution market is expected to grow the most in the upcoming years. The increasing cases of dehydration among people due to unhealthy and stressful lifestyles further increase the demand for Oral rehydration solutions, leading to market growth. Rising morbidity and mortality among hospital patients and the general population increase the ORS supply demand at local pharmacists, directly driving the OPRS global market. The active government campaigns about the ORS benefits and awareness among people about the positive impacts of ORS are further propelling its market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral rehydration solution (ORS). The growth and trends of oral rehydration solution industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the oral rehydration solution (ORS) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Sales

  • OTC Products
  • Prescription

By Dosage Form

  • Powder
  • Liquid
  • Tablet

By Customer Age

  • Children
  • Adult

By Indication

  • Diarrhea
  • Gastroenteritis
  • Electrolyte Imbalance
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Oral Rehydration Solution market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oral rehydration solution (ORS) market include FDC Limited, Cipla, Wallace Pharmaceuticals, Zydus Cadila Healthcare Ltd, Shereya Life Sciences, Mankind Pharma, Intas Pharmaceuticals Ltd., Sun Pharma, Dr Reddy's, Alkem, Lupin, Cadila, RPG Life Sciences, Casca Remedies Pvt. Ltd., Halewood Laboratories Pvt. Ltd., Healthy Life Pharma Private Limited, Okasa Pharma Pvt. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORAL REHYDRATION SOLUTION (ORS) - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Sales
    • 3.7.2 Market Attractiveness Analysis By Dosage Form
    • 3.7.3 Market Attractiveness Analysis By Customer Age
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY PRODUCT SALES

  • 6.1 Overview by Product Sales
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Sales
  • 6.4 OTC Products Historic and Forecast Sales by Regions
  • 6.5 Prescription Historic and Forecast Sales by Regions

7 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY DOSAGE FORM

  • 7.1 Overview by Dosage Form
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Dosage Form
  • 7.4 Powder Historic and Forecast Sales by Regions
  • 7.5 Liquid Historic and Forecast Sales by Regions
  • 7.6 Tablet Historic and Forecast Sales by Regions

8 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY CUSTOMER AGE

  • 8.1 Overview by Customer Age
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Customer Age
  • 8.4 Children Historic and Forecast Sales by Regions
  • 8.5 Adult Historic and Forecast Sales by Regions

9 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Diarrhea Historic and Forecast Sales by Regions
  • 9.5 Gastroenteritis Historic and Forecast Sales by Regions
  • 9.6 Electrolyte Imbalance Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 10.1 Overview by Distribution Channel
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Distribution Channel
  • 10.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 10.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 10.6 Online Pharmacies Historic and Forecast Sales by Regions

11 . GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE ORAL REHYDRATION SOLUTION (ORS) COMPANIES

  • 12.1. Oral Rehydration Solution (Ors) Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF ORAL REHYDRATION SOLUTION (ORS) INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. FDC Limited
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Cipla
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Wallace Pharmaceuticals
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Zydus Cadila Healthcare Ltd
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Shereya Life Sciences
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Mankind Pharma
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Intas Pharmaceuticals Ltd.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Sun Pharma
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Dr Reddy's
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Alkem
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Lupin
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Cadila
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. RPG Life Sciences
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. Casca Remedies Pvt. Ltd.
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. Halewood Laboratories Pvt. Ltd.
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments
  • 13.18. Healthy Life Pharma Private Limited
    • 13.18.1. Company Overview
    • 13.18.2. Company Revenue
    • 13.18.3. Products
    • 13.18.4. Recent Developments
  • 13.19. Okasa Pharma Pvt. Ltd.
    • 13.19.1. Company Overview
    • 13.19.2. Company Revenue
    • 13.19.3. Products
    • 13.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Sales (USD MN)
  • OTC Products Market Sales by Geography (USD MN)
  • Prescription Market Sales by Geography (USD MN)
  • Analysis Market by Dosage Form (USD MN)
  • Powder Market Sales by Geography (USD MN)
  • Liquid Market Sales by Geography (USD MN)
  • Tablet Market Sales by Geography (USD MN)
  • Analysis by Customer Age (USD MN)
  • Children Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Diarrhea Market Sales by Geography (USD MN)
  • Gastroenteritis Market Sales by Geography (USD MN)
  • Electrolyte Imbalance Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Oral Rehydration Solution (Ors) Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oral Rehydration Solution (Ors) Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Rehydration Solution (Ors) Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Sales
  • Market Attractiveness Analysis by Dosage Form
  • Market Attractiveness Analysis by Customer Age
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Sales (USD MN)
  • OTC Products Market Sales by Geography (USD MN)
  • Prescription Market Sales by Geography (USD MN)
  • Global Market Analysis by Dosage Form (USD MN)
  • Powder Market Sales by Geography (USD MN)
  • Liquid Market Sales by Geography (USD MN)
  • Tablet Market Sales by Geography (USD MN)
  • Global Market Analysis by Customer Age (USD MN)
  • Children Market Sales by Geography (USD MN)
  • Adult Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Diarrhea Market Sales by Geography (USD MN)
  • Gastroenteritis Market Sales by Geography (USD MN)
  • Electrolyte Imbalance Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.